List of insiders holdings for Foghorn Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 2026-10-05 16:28:27 | 17,858,465 0 | 17,858,465 | Form 3 |
| 2 | Flagship Pioneering LLC Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR Director 10% Owner | 2026-01-15 17:00:05 | 0 4,470,936 | 4,470,936 | Form 4 |
| 3 | KADOCH CIGALL Director | 2022-09-02 08:07:29 | 323,530 3,329,379 | 3,652,909 | Form 4 |
| 4 | Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner | 2020-10-28 06:02:15 | 1,231,081 0 | 1,231,081 | Form 4 |
| 5 | Reine Allan Chief Financial Officer | 2024-01-17 16:01:54 | 748,188 0 | 748,188 | Form 4 |
| 6 | DECICCO CARL Chief Scientific Officer | 2021-12-13 20:37:39 | 583,551 0 | 583,551 | Form 4 |
| 7 | Cavalie Fanny Chief Strategy/Bus Ops Officer | 2024-06-24 16:01:17 | 482,161 0 | 482,161 | Form 4 |
| 8 | Maynard Ryan D Chief Financial Officer | 2026-02-24 16:02:39 | 400,000 0 | 400,000 | Form 4 |
| 9 | Agresta Samuel Chief Medical Officer | 2023-09-13 16:02:28 | 376,891 0 | 376,891 | Form 4 |
| 10 | Bellon Steven F. Chief Scientific Officer | 2026-02-02 16:01:11 | 300,000 0 | 300,000 | Form 4 |
| 11 | Cardama Alfonso Quintas Chief Medical Officer | 2026-02-02 16:03:02 | 300,000 0 | 300,000 | Form 4 |
| 12 | LaCascia Michael Chief Legal Officer | 2026-02-02 16:03:48 | 295,000 0 | 295,000 | Form 4 |
| 13 | GOTTSCHALK ADRIAN Chief Executive Officer | 2026-04-13 16:01:20 | 0 270,912 | 270,912 | Form 4 |
| 14 | Costa Carlos Chief People Officer | 2026-02-02 16:04:42 | 230,000 0 | 230,000 | Form 4 |
| 15 | Rivkin Anna Chief Business Officer | 2026-02-02 16:02:22 | 165,000 0 | 165,000 | Form 4 |
| 16 | Baselga Jose Director | 2020-10-22 20:56:11 | 94,594 0 | 94,594 | Form 3 |
| 17 | PARSHALL B LYNNE Director | 2026-06-25 16:01:18 | 28,000 0 | 28,000 | Form 4 |
| 18 | Lynch Thomas J. Jr. Director | 2026-06-25 16:06:54 | 28,000 0 | 28,000 | Form 4 |
| 19 | Duty Stuart Director | 2026-06-25 16:06:03 | 28,000 0 | 28,000 | Form 4 |
| 20 | Biller Scott Director | 2026-06-25 16:05:13 | 28,000 0 | 28,000 | Form 4 |
| 21 | Gallagher Neil Director | 2026-06-25 16:04:20 | 28,000 0 | 28,000 | Form 4 |
| 22 | Mendelsohn Michael Director | 2026-06-25 16:03:35 | 28,000 0 | 28,000 | Form 4 |
| 23 | SMITH IAN F Director | 2026-06-25 16:02:49 | 28,000 0 | 28,000 | Form 4 |
| 24 | GILL SIMBA Director | 2026-06-25 16:01:48 | 28,000 0 | 28,000 | Form 4 |
| 25 | Cole Douglas G. Director | 2026-06-25 16:00:41 | 28,000 0 | 28,000 | Form 4 |
| 26 | Humer Kristian Chief Financial Officer | 2025-11-17 16:01:17 | 0 0 | 0 | Form 4 |
| 27 | Koppel Adam Director | 2024-12-30 07:54:56 | 0 0 | 0 | Form 4 |